Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Hamadani

Showing results (51-60 of 459) with videos related to

Pageof 46
Sort By:
Blood|March 26, 2008
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantationMehdi Hamadani, Farrukh T Awan, Steven M Devine
Transplantation and Cellular Therapy|March 29, 2023
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell TherapyNausheen Ahmed, Zahra Mahmoudjafari, Mehdi Hamadani, et al.
The Medical Journal of Australia|September 27, 2006
Infected atrial myxomaAhmed Awab, Mehdi Hamadani, Bhanu Sud, et al.
Ejhaem|October 17, 2024
Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirineMehdi Hamadani, Melanie Lucero, Jakob D DeVos, et al.
British Journal of Haematology|October 21, 2021
Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignanciesBinod Dhakal, Saurabh Chhabra, Bipin N Savani, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 1, 2021
Breast Implant-associated Anaplastic Large Cell LymphomaShaikha Alotaibi, Mehdi Hamadani, Mubarak Al-Mansour, et al.
Southern Medical Journal|April 3, 2007
GastroparesisTauseef Ali, Muhammad Hasan, Mehdi Hamadani, et al.
Bone Marrow Research|October 26, 2012
Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphomaAbraham S Kanate, Mohamed A Kharfan-Dabaja, Mehdi Hamadani
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2021
Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of TherapiesMehdi Hamadani, Laura Liao, Tony Yang, et al.
World Journal of Transplantation|October 1, 2015
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomasNarendranath Epperla, Timothy S Fenske, Parameswaran N Hari, et al.
Pageof 46

Showing results (51-60 of 459) with videos related to

Sort By:
Pageof 46
Blood|March 26, 2008
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantationMehdi Hamadani, Farrukh T Awan, Steven M Devine
Transplantation and Cellular Therapy|March 29, 2023
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell TherapyNausheen Ahmed, Zahra Mahmoudjafari, Mehdi Hamadani, et al.
The Medical Journal of Australia|September 27, 2006
Infected atrial myxomaAhmed Awab, Mehdi Hamadani, Bhanu Sud, et al.
Ejhaem|October 17, 2024
Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirineMehdi Hamadani, Melanie Lucero, Jakob D DeVos, et al.
British Journal of Haematology|October 21, 2021
Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignanciesBinod Dhakal, Saurabh Chhabra, Bipin N Savani, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 1, 2021
Breast Implant-associated Anaplastic Large Cell LymphomaShaikha Alotaibi, Mehdi Hamadani, Mubarak Al-Mansour, et al.
Southern Medical Journal|April 3, 2007
GastroparesisTauseef Ali, Muhammad Hasan, Mehdi Hamadani, et al.
Bone Marrow Research|October 26, 2012
Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphomaAbraham S Kanate, Mohamed A Kharfan-Dabaja, Mehdi Hamadani
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2021
Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of TherapiesMehdi Hamadani, Laura Liao, Tony Yang, et al.
World Journal of Transplantation|October 1, 2015
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomasNarendranath Epperla, Timothy S Fenske, Parameswaran N Hari, et al.
Pageof 46